Search results for "Occult"

showing 10 items of 92 documents

Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: Results from the IMPATTO study

2019

To evaluate the impact of faecal immunochemical test (FIT) screening on stage distribution at diagnosis, and to estimate relative incidence rates by stage in screened at first and subsequent rounds vs. unscreened. We included all incident cases occurring in 2000-2008 in 50- to 71-year-olds residing in areas with an FIT-screening programme. Multinomial logistic models were computed to estimate the relative risk ratio (RRR) of stages I and IV, compared to stage II + III, adjusting for age, sex, geographical area, and incidence year. Proportions were then used to estimate incidence rate ratios (IRR) by stage for screened subjects at the first and at subsequent rounds vs. unscreened subjects, a…

MaleCancer Researchmedicine.medical_specialtyColorectal cancerPrevalenceSocio-culturaleColonoscopyColorectal NeoplasmSettore MED/42 - Igiene Generale E Applicatacolorectal cancer screeningScreening programmeFeces03 medical and health sciences0302 clinical medicinecolonoscopyFaecal immunochemical test colonoscopy colorectal cancer screening epidemiology cancer registriesInternal medicineEpidemiologymedicineHumansStage (cooking)Early Detection of CancerAgedNeoplasm StagingProportional Hazards Modelscancer registriemedicine.diagnostic_testFaecal immunochemical testbusiness.industryIncidence (epidemiology)IncidenceMiddle Agedmedicine.diseaseImmunohistochemistryOncologyItalycancer registries030220 oncology & carcinogenesisRelative riskOccult BloodepidemiologyFeceFemaleNeoplasm GradingColorectal NeoplasmsbusinessHuman
researchProduct

Pattern of occult nodal relapse diagnosed with 18F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only rad…

2014

Abstract Introduction The purpose of this study was to describe the pattern of nodal relapse with 18 F-fluoro-choline (FCH) Positron Emission Tomography/Computerized Tomography (PET/CT) in prostate cancer patients after radiotherapy. Materials and methods Eighty-three patients had a FCH PET/CT at time of biochemical failure. Of 65 patients with positive findings, 33 had positive nodes. This analysis included 31 patients who had undergone prior prostate-only radiotherapy with or without a prior radical prostatectomy. Each FCH positive node was assigned to a lymph node station with respect to the CTV defined by the RTOG guidelines (CTV RTOG ). 3D mapping was performed after each node was manu…

MaleFluorine Radioisotopesmedicine.medical_treatment[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineMultimodal Imaging[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicineCholineProstate cancerProstatemedicineHumansRadiology Nuclear Medicine and imagingLymph nodeComputingMilieux_MISCELLANEOUSSalvage TherapyPET-CTmedicine.diagnostic_testProstatectomybusiness.industryProstatic NeoplasmsHematologyProstate-Specific Antigenmedicine.diseaseOccult3. Good healthRadiation therapymedicine.anatomical_structureOncologyPositron emission tomographyLymphatic MetastasisPositron-Emission TomographyKallikreinsLymph NodesNeoplasm Recurrence LocalRadiopharmaceuticalsNuclear medicinebusinessTomography X-Ray Computed
researchProduct

Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

2003

Background & Aims: Occult hepatitis B virus (HBV) infection is characterized by persistence of HBV DNA into the tissue of hepatitis B surface antigen-negative individuals. The clinical relevance of this peculiar infection is still under debate. In particular, the impact of occult HBV infection in cases of hepatocellular carcinoma (HCC) is uncertain. We investigated the prevalence and molecular status of occult HBV in patients with HCC. Methods: We tested tumor tissues from 107 patients with HCC and the corresponding nontumor liver tissue from 72 of these patients for HBV DNA. We also examined liver specimens from 192 patients with chronic hepatitis. All cases were hepatitis B surface antige…

MaleHBV; HCC; occultHepatitis B virusCarcinoma HepatocellularOCCULT HEPATITIS B VIRUS INFECTION; HEPATOCELLULAR CARCINOMA; HBV DNA; TUNOR AND NONTUMOR LIVER TISSUES; HBV TRANSCRIPTS; HBV COVALENTLY CLOSED CIRCULAR DNA; INTEGRATED AND EPISOMAL HBV DNATranscription GeneticOCCULT HEPATITIS B VIRUS INFECTIONHBV TRANSCRIPTSGenome ViralBiologyVirus Replicationmedicine.disease_causeChronic liver diseaseHepatitis B ChronicmedicineCarcinomaHBVHumansHEPATOCELLULAR CARCINOMATUNOR AND NONTUMOR LIVER TISSUESHCCAgedHepatitis B virusHepatologyINTEGRATED AND EPISOMAL HBV DNALiver NeoplasmsGastroenterologyvirus diseasescccDNAMiddle AgedHepatitis Bmedicine.diseaseOccultVirologydigestive system diseaseshepatitis B surface antigenLiverViral replicationHBV DNAoccultHepatocellular carcinomaDNA ViralImmunologyFemaleHBV COVALENTLY CLOSED CIRCULAR DNAInfection OBI
researchProduct

Viral Sequence Analysis of Occult HBV Infection and Its Reactivation in Immunosuppressed Patients

2012

Mechanisms associated with reactivation of hepatitis B virus (HBV) in patients with occult HBV infection (OBI) remain unclear. In some cases immunosuppression is an enhancer of viral replication. However, not all patients with OBI who undergo immunosuppression experience reactivation. This study explores the role of viral heterogeneity as a determinant of occult HBV reactivation. HBV genotype, mutation patterns and quasispecies were assessed by sequencing the PreS/S region of 16 patients with OBI undergoing chemotherapy, 3 of whom experienced a OBI reactivation. The latter were also assessed at the time of reactivation. Phylogenetic analysis identified low nucleotide and amino acid diversit…

MaleHepatitis B virusSettore MED/07 - Microbiologia E Microbiologia ClinicaSettore MED/12 - GastroenterologiaGenotypeoccult HBV HBV reactivation phylogenetic analysismolecular epidemiologyGenetic VariationSequence Analysis DNAHepatitis BImmunocompromised HostDNA ViralHumansFemaleRetrospective Studies
researchProduct

Additional mailing phase for FIT after a medical offer phase: The best way to improve compliance with colorectal cancer screening in France

2017

International audience; Background: Compliance with colorectal cancer screening is critical to its effectiveness. The organisation of the mass screening programme in France has recently been modified with no evaluation of the consequences.Aims: To evaluate the impact of the way the screening test is delivered on compliance.Patients and Methods: During the first six months of the screening campaign (Ille-Vilaine, Brittany), general practitioners were asked to propose a faecal immunochemical test (FIT), OC-Sensor, to individuals at average risk for colorectal cancer (n = 152,097). A subset of non-participants in the medical phase (n = 13,071) was randomly chosen to receive a reminder that inc…

MaleMedical consultationColorectal cancer[ SDV.CAN ] Life Sciences [q-bio]/Cancer0302 clinical medicineMass ScreeningEarly Detection of Cancermedia_commonGastroenterology[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieMiddle Aged3. Good healthTest (assessment)Colorectal cancer screeningOccult Blood030220 oncology & carcinogenesisScreening[ SDV.MHEP.HEG ] Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyFemale030211 gastroenterology & hepatologyFranceColorectal NeoplasmsCompliancemedicine.medical_specialtyReminder Systemseducation[SDV.CAN]Life Sciences [q-bio]/CancerCompliance (psychology)03 medical and health sciences[SDV.CAN] Life Sciences [q-bio]/CancermedicineHumansmedia_common.cataloged_instancePostal ServiceEuropean unionUptake rateMass screeningAgedGynecologyHepatologybusiness.industry[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyImmunochemical testmedicine.diseaseColorectal cancer[SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieFamily medicinePatient Compliance[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessDigestive and Liver Disease
researchProduct

Informed participation in the Valencian Community Colorectal Cancer Screening Programme from a gender perspective.

2018

Abstract Objective: To examine the factors that influence informed participation in a Colorectal Cancer Screening Programme (CRCSP) from a gender perspective. Methods: Cross-sectional telephone survey directed to men and women invited to participate (2009-2010) in the Valencian Community CRCSP (Spain). Sample size: 785 subjects. Outcome variables: participation in CRCSP and being informed. Bivariate and multivariate analysis using logistic regression models (95% confidence interval [95%CI], p <0.05). Results: Being a woman (odds ratio [OR]: 1.52; 95%CI: 1.06-2.19), receiving information from a general practitioner (OR: 1.64; 95%CI: 1.05-2.55) and being informed (OR: 1.54; 95%CI: 1.08-2.21) …

MaleMultivariate analysisToma de decisión informadaGeneral PracticeLogistic regressionValencian community0302 clinical medicine030212 general & internal medicineEarly Detection of Cancerlcsh:Public aspects of medicineMiddle AgedColorectal cancer screening030220 oncology & carcinogenesisEarly detection of cancerOccult BloodFemaleInformed decision makingColorectal NeoplasmsAttitude to Healthmedicine.medical_specialtyInformation Seeking BehaviorSampling StudiesColorectal neoplasmInterviews as Topic03 medical and health sciencesSex FactorsPatient Education as TopicGender identitymedicineHumansCáncer colorrectalAgedPrimary Health Carebusiness.industryPerspective (graphical)Public Health Environmental and Occupational Healthlcsh:RA1-1270Odds ratioConfidence intervalSurgeryParticipaciónCross-Sectional StudiesDetección precoz del cáncerSocioeconomic FactorsSample size determinationFamily medicineGéneroPatient participationPatient ParticipationbusinessGaceta sanitaria
researchProduct

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2013

MaleOncologyOrganoplatinum CompoundsOxaloacetatesColorectal cancerLeucovorinColonoscopyChromosome DisordersDeoxycytidineRisk FactorsAntineoplastic Combined Chemotherapy ProtocolsIntestinal MucosaSigmoidoscopyEarly Detection of Cancermedicine.diagnostic_testFollow up studiesColonoscopyHematologyEuropeClinical PracticeTreatment OutcomeOncologyDiagnosis treatmentChemotherapy AdjuvantLymphatic MetastasisOccult BloodColonic NeoplasmsFemaleFluorouracilChromosome Deletionmedicine.drugRiskmedicine.medical_specialtyAntineoplastic AgentsRisk AssessmentCapecitabineInternal medicinemedicineHumansCapecitabineNeoplasm Stagingbusiness.industryGeneral surgeryCancerSigmoidoscopymedicine.diseaseCarcinoembryonic AntigenNeoplasm Recurrence LocalChromosomes Human Pair 18businessFollow-Up StudiesAnnals of Oncology
researchProduct

Socio-geographical determinants of colonoscopy uptake after faecal occult blood test

2010

Survival from colorectal cancer is poorer in patients of lower socioeconomic level, or living far from the cancer reference centre.To evaluate the impact of material deprivation and geographical remoteness on the uptake of colonoscopy after a positive screening faecal occult blood test.Data from two large French average-risk population-based trials comparing two faecal occult blood tests were used. Compliance with colonoscopy after a positive faecal occult blood test was analysed using a logistic model and a Cox model considering time between faecal occult blood test and colonoscopy. Covariates studied were sex, age, distance to nearest gastroenterologist, distance to regional capital, and …

MaleOncologymedicine.medical_specialtyTime FactorsColorectal cancerPopulationColonoscopyLogistic regressionHealth Services AccessibilityInternal medicinemedicineHumanseducationSocioeconomic statusMass screeningAgedProportional Hazards Modelseducation.field_of_studyHepatologymedicine.diagnostic_testbusiness.industryProportional hazards modelGastroenterologyCancerColonoscopyMiddle Agedmedicine.diseaseLogistic ModelsSocioeconomic FactorsOccult BloodPatient ComplianceFemaleFranceColorectal NeoplasmsbusinessDigestive and Liver Disease
researchProduct

Long-term effect of faecal occult blood screening on incidence and mortality from colorectal cancer

2014

Abstract Background Several randomized trials have shown a reduction of colorectal cancer mortality by screening using guaiac-based faecal occult blood tests. However, little is known on the long-term effect of screening at the population level in everyday practice. Methods Small-sized geographic areas including a total of 91,199 individuals were allocated to either biennal screening using the Hemoccult-II test or no screening. The expected mortality and incidence in the cohort invited to screening was determined using mortality and incidence in the non-screened population. Results Colorectal cancer mortality was significantly lower in the population invited to screening than in the non-scr…

Malemedicine.medical_specialtyColorectal cancerPopulationlaw.inventionRandomized controlled triallawInternal medicinemedicineHumansMass ScreeningTerm effecteducationEarly Detection of CancerMass screeningAgedGynecologyeducation.field_of_studyHepatologybusiness.industryIncidenceIncidence (epidemiology)GastroenterologyMiddle Agedmedicine.diseaseStandardized mortality ratioOccult BloodCohortFemaleFranceColorectal NeoplasmsbusinessFollow-Up StudiesDigestive and Liver Disease
researchProduct

Fecal Blood Loss in Patients With Colonic Polyps: A Comparison of Measurements With 51Chromium-Labeled Erythrocytes and With the Haemoccult Test

1982

Abstract The quantitative determinations of fecal daily blood loss after intravenous administration of 51Cr-labeled erythrocytes in 44 patients with colonic polyps and in 11 controls were compared with the results of the daily performed Haemoccult test without dietary restrictions. A total of 642 stool specimens was analyzed for 51Cr loss and the Haemoccult test. The mean fecal daily blood loss in the 34 patients with adenomatous polyps of the descending colon and rectosigmoid was 1.36 ± 0.14 ml/day (mean ± SEM), in the 10 patients with polyps of the ascending and transverse colon it was 1.28 ± 0.31 ml/day, and in the 11 controls 0.62 ± 0.07 ml/day. There was no positive Haemoccult test in …

Malemedicine.medical_specialtyErythrocytesGastroenterologyDescending colonMelenaBlood lossInternal medicinemedicineHumansAscending colonLarge intestineFecesGastrointestinal tractIsotopes of chromiumHepatologybusiness.industryGastroenterologyTransverse colonIntestinal PolypsMiddle AgedChromium Radioisotopesdigestive system diseasesmedicine.anatomical_structureOccult BloodColonic NeoplasmsFemalebusinessGastroenterology
researchProduct